Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics. AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into...
You must be a Standard 1 Year member to access this content.
Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Synthego in the transaction. EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego’s engineered cell solutions...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing Veracyte in the transaction, and Meitar is representing C2i Genomics. Veracyte, Inc. (Nasdaq: VCYT) announced it has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Snell & Wilmer represented Insight Enterprises in the transaction, and Fenwick & West represented SADA. Insight Enterprises (NASDAQ:NSIT) announced it has completed the acquisition of SADA, a leading cloud...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Chinook Therapeutics, Inc. on the transaction, while Hogan Lovells US LLP represented Novartis AG. Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Fenwick advised Shockwave Medical, Inc. on the deal. Shockwave Medical, Inc. (NASDAQ: SWAV), a medical device company focused on the development of Intravascular Lithotripsy (IVL) to...
You must be a Standard 1 Year member to access this content.
Foros acted as financial advisor and Fenwick & West and Slaughter and May acted as legal advisor to Zuora. Stifel acted as financial advisor and Cooley...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Snowflake on the deal while Fenwick represented Streamlit. Snowflake executed the acquisition of Streamlit, a framework built to simplify and accelerate the creation of...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Narvar on the deal. Narvar, a platform focused on driving customer loyalty through seamless post-purchase experiences, announced its acquisition of Lumi, a digital...
You must be a Standard 1 Year member to access this content.
